Recent Finacing
Recent Raise
Beckley Psytech is a UK clinical-stage pharmaceutical company developing short-duration psychedelic therapies—intranasal 5-MeO-DMT (Phase IIb for TRD), IV psilocin (Phase I/IIa), low-dose psilocybin trials, and digital patient-support tools.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
